{"id":"https://openalex.org/W2144325076","doi":"https://doi.org/10.1053/eujp.2001.0282","title":"Mechanism of opioid dependence and interaction between opioid receptors","display_name":"Mechanism of opioid dependence and interaction between opioid receptors","publication_year":2001,"publication_date":"2001-12-01","ids":{"openalex":"https://openalex.org/W2144325076","doi":"https://doi.org/10.1053/eujp.2001.0282","mag":"2144325076","pmid":"https://pubmed.ncbi.nlm.nih.gov/11798220"},"language":"en","primary_location":{"id":"doi:10.1053/eujp.2001.0282","doi":"https://doi.org/10.1053/eujp.2001.0282","is_oa":false,"landing_page_url":"https://doi.org/10.1053/eujp.2001.0282","pdf_url":null,"source":{"id":"https://openalex.org/S143744428","display_name":"European Journal of Pain","issn_l":"1090-3801","issn":["1090-3801","1532-2149"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pain","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113616619","display_name":"Tsutomu Suzuki","orcid":"https://orcid.org/0009-0006-1414-3039","observed_orcids":["https://orcid.org/0009-0006-1414-3039"]},"institutions":[{"id":"https://openalex.org/I36296616","display_name":"Hoshi University","ror":"https://ror.org/01mrvbd33","country_code":"JP","type":"education","lineage":["https://openalex.org/I36296616"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Tsutomu Suzuki","raw_affiliation_strings":["Department of Toxicology, School of Pharmacy, Hoshi University, Tokyo, Japan. suzuki@hoshi.ac.jp","Department of Toxicology, School of Pharmacy, Hoshi University, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Toxicology, School of Pharmacy, Hoshi University, Tokyo, Japan. suzuki@hoshi.ac.jp","institution_ids":["https://openalex.org/I36296616"]},{"raw_affiliation_string":"Department of Toxicology, School of Pharmacy, Hoshi University, Tokyo, Japan","institution_ids":["https://openalex.org/I36296616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064006153","display_name":"Yayoi Kishimoto","orcid":"https://orcid.org/0000-0002-1674-2696","observed_orcids":["https://orcid.org/0000-0002-1674-2696"]},"institutions":[{"id":"https://openalex.org/I36296616","display_name":"Hoshi University","ror":"https://ror.org/01mrvbd33","country_code":"JP","type":"education","lineage":["https://openalex.org/I36296616"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yayoi Kishimoto","raw_affiliation_strings":["Department of Toxicology, School of Pharmacy, Hoshi University, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Toxicology, School of Pharmacy, Hoshi University, Tokyo, Japan","institution_ids":["https://openalex.org/I36296616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032030704","display_name":"Satoru Ozaki","orcid":"https://orcid.org/0000-0002-2322-8804","observed_orcids":["https://orcid.org/0000-0002-2322-8804"]},"institutions":[{"id":"https://openalex.org/I36296616","display_name":"Hoshi University","ror":"https://ror.org/01mrvbd33","country_code":"JP","type":"education","lineage":["https://openalex.org/I36296616"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Satoru Ozaki","raw_affiliation_strings":["Department of Toxicology, School of Pharmacy, Hoshi University, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Toxicology, School of Pharmacy, Hoshi University, Tokyo, Japan","institution_ids":["https://openalex.org/I36296616"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108416252","display_name":"Minoru Narita","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36296616","display_name":"Hoshi University","ror":"https://ror.org/01mrvbd33","country_code":"JP","type":"education","lineage":["https://openalex.org/I36296616"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Minoru Narita","raw_affiliation_strings":["Department of Toxicology, School of Pharmacy, Hoshi University, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Toxicology, School of Pharmacy, Hoshi University, Tokyo, Japan","institution_ids":["https://openalex.org/I36296616"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5113616619"],"corresponding_institution_ids":["https://openalex.org/I36296616"],"apc_list":{"value":4310,"currency":"USD","value_usd":4310},"apc_paid":null,"fwci":0.7385,"has_fulltext":false,"cited_by_count":23,"citation_normalized_percentile":{"value":0.61602633,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"5","issue":"SA","first_page":"63","last_page":"65"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.6435999870300293,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.6435999870300293,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10196","display_name":"Pain Mechanisms and Treatments","score":0.31790000200271606,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.013799999840557575,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/opioid-use-disorder","display_name":"opioid use disorder","score":0.8600000143051147},{"id":"https://openalex.org/keywords/morphine-reward","display_name":"morphine reward","score":0.6639999747276306},{"id":"https://openalex.org/keywords/kappa-opioid-receptor","display_name":"kappa opioid receptor","score":0.753000020980835},{"id":"https://openalex.org/keywords/mu-opioid-receptor","display_name":"mu-opioid receptor","score":0.968999981880188},{"id":"https://openalex.org/keywords/delta-opioid-receptor","display_name":"delta opioid receptor","score":0.8370000123977661},{"id":"https://openalex.org/keywords/inflammatory-pain","display_name":"inflammatory pain","score":0.5070000290870667},{"id":"https://openalex.org/keywords/formalin-induced-hyperalgesia","display_name":"formalin-induced hyperalgesia","score":0.7390000224113464},{"id":"https://openalex.org/keywords/carrageenan-induced-paw-edema","display_name":"carrageenan-induced paw edema","score":0.8190000057220459},{"id":"https://openalex.org/keywords/conditioned-place-preference","display_name":"conditioned place preference","score":0.9700000286102295},{"id":"https://openalex.org/keywords/nor-binaltorphimine","display_name":"nor-binaltorphimine","score":0.9409999847412109},{"id":"https://openalex.org/keywords/naltrindole","display_name":"naltrindole","score":0.9990000128746033},{"id":"https://openalex.org/keywords/dopamine-turnover","display_name":"dopamine turnover","score":0.8169999718666077},{"id":"https://openalex.org/keywords/nucleus-accumbens","display_name":"nucleus accumbens","score":0.9959999918937683}],"concepts":[{"id":"https://openalex.org/C35124327","wikidata":"https://www.wikidata.org/wiki/Q5159285","display_name":"Conditioned place preference","level":3,"score":0.7948389649391174},{"id":"https://openalex.org/C2777389121","wikidata":"https://www.wikidata.org/wiki/Q81225","display_name":"Morphine","level":2,"score":0.7254589200019836},{"id":"https://openalex.org/C2777953665","wikidata":"https://www.wikidata.org/wiki/Q3743642","display_name":"Naltrindole","level":5,"score":0.7132722735404968},{"id":"https://openalex.org/C2779245659","wikidata":"https://www.wikidata.org/wiki/Q1633866","display_name":"Hyperalgesia","level":4,"score":0.6218504309654236},{"id":"https://openalex.org/C184389661","wikidata":"https://www.wikidata.org/wiki/Q14897645","display_name":"\u03ba-opioid receptor","level":4,"score":0.5930160284042358},{"id":"https://openalex.org/C2776552330","wikidata":"https://www.wikidata.org/wiki/Q1476178","display_name":"Nucleus accumbens","level":3,"score":0.5667343139648438},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.5581202507019043},{"id":"https://openalex.org/C14397066","wikidata":"https://www.wikidata.org/wiki/Q14911924","display_name":"\u03bc-opioid receptor","level":4,"score":0.51552414894104},{"id":"https://openalex.org/C2780820201","wikidata":"https://www.wikidata.org/wiki/Q173235","display_name":"Analgesic","level":2,"score":0.5076273679733276},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4936457872390747},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4732896685600281},{"id":"https://openalex.org/C15490471","wikidata":"https://www.wikidata.org/wiki/Q2734305","display_name":"Nociception","level":3,"score":0.4412398636341095},{"id":"https://openalex.org/C2779004600","wikidata":"https://www.wikidata.org/wiki/Q18357784","display_name":"Opioidergic","level":5,"score":0.43936723470687866},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4030543863773346},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3697078824043274},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3339865207672119},{"id":"https://openalex.org/C2779886867","wikidata":"https://www.wikidata.org/wiki/Q421797","display_name":"Opioid receptor","level":4,"score":0.28946977853775024},{"id":"https://openalex.org/C2778750930","wikidata":"https://www.wikidata.org/wiki/Q4540629","display_name":"(+)-Naloxone","level":4,"score":0.10427922010421753}],"mesh":[{"descriptor_ui":"D000701","descriptor_name":"Analgesics, Opioid","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002351","descriptor_name":"Carrageenan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002908","descriptor_name":"Chronic Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003213","descriptor_name":"Conditioning, Psychological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007249","descriptor_name":"Inflammation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009020","descriptor_name":"Morphine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009293","descriptor_name":"Opioid-Related Disorders","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D009293","descriptor_name":"Opioid-Related Disorders","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D009619","descriptor_name":"Nociceptors","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D010146","descriptor_name":"Pain","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010146","descriptor_name":"Pain","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D010146","descriptor_name":"Pain","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D010147","descriptor_name":"Pain Measurement","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011957","descriptor_name":"Receptors, Opioid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1053/eujp.2001.0282","doi":"https://doi.org/10.1053/eujp.2001.0282","is_oa":false,"landing_page_url":"https://doi.org/10.1053/eujp.2001.0282","pdf_url":null,"source":{"id":"https://openalex.org/S143744428","display_name":"European Journal of Pain","issn_l":"1090-3801","issn":["1090-3801","1532-2149"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pain","raw_type":"journal-article"},{"id":"pmid:11798220","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11798220","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of pain (London, England)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":1,"referenced_works":["https://openalex.org/W2016733882"],"related_works":["https://openalex.org/W2950787701","https://openalex.org/W2098125486","https://openalex.org/W1989362268","https://openalex.org/W7098222111","https://openalex.org/W2397099616","https://openalex.org/W2010104382","https://openalex.org/W2070078848","https://openalex.org/W1974494333","https://openalex.org/W2014554266","https://openalex.org/W2415716958"],"abstract_inverted_index":{"Clinical":[0],"studies":[1],"have":[2],"demonstrated":[3],"that":[4,124,212],"when":[5],"opiates":[6,37],"are":[7,18],"used":[8],"to":[9,29,112,136],"control":[10,115],"cancer":[11],"pain,":[12],"psychological":[13],"dependence":[14],"and":[15,56,149,154,199,223],"analgesic":[16],"tolerance":[17],"not":[19,171],"a":[20,83],"major":[21],"concern.":[22],"The":[23,63,69,184],"present":[24],"study":[25],"was,":[26],"therefore,":[27],"designed":[28],"investigate":[30],"the":[31,48,52,59,97,102,107,113,118,129,138,143,158,161,174,177,192,200,205,225,239,242],"modulation":[32],"of":[33,36,51,72,132,140,145,160,176,227,241,244],"rewarding":[34,70,130,245],"effects":[35,144,246],"under":[38,165,197],"inflammatory":[39,221],"chronic":[40,220],"pain.":[41],"Formalin":[42,55],"or":[43],"carrageenan":[44,57],"was":[45,74,89,195,202],"injected":[46],"into":[47],"plantar":[49],"surface":[50],"rat":[53],"paw.":[54],"reduced":[58],"paw":[60],"pressure":[61],"threshold.":[62],"hyperalgesia":[64],"lasted":[65],"for":[66],"9-13":[67],"days.":[68],"effect":[71,88,131],"morphine":[73],"evaluated":[75],"by":[76,204,219,248],"conditioned":[77],"place":[78,85,104,163,179],"preference":[79,105,164,180],"paradigm.":[80],"Morphine":[81],"produced":[82,247],"significant":[84],"preference.":[86],"This":[87],"significantly":[90],"attenuated":[91],"in":[92,106,181,187,191,234,238],"inflamed":[93,108,182],"groups":[94],"compared":[95],"with":[96,147,207],"respective":[98,114],"non-inflamed":[99],"groups.":[100,183],"Furthermore,":[101],"morphine-induced":[103,162,178,185],"group":[109],"gradually":[110],"recovered":[111],"level":[116],"as":[117],"inflammation":[119,166],"healed.":[120],"We":[121],"also":[122],"found":[123],"kappa-receptor":[125],"agonists":[126],"markedly":[127],"inhibited":[128],"mu-receptor":[133],"agonists.":[134],"Therefore,":[135],"elucidate":[137],"mechanism":[139],"this":[141],"attenuation,":[142],"pretreatment":[146,206],"kappa-":[148],"delta-receptor":[150],"antagonists,":[151],"nor-binaltorphimine":[152],"(nor-BNI)":[153],"naltrindole":[155],"(NTI),":[156],"on":[157],"development":[159,243],"were":[167],"examined.":[168],"Nor-BNI,":[169],"but":[170],"NTI,":[172],"eliminated":[173],"suppression":[175,201,240],"increase":[186],"dopamine":[188],"(DA)":[189],"turnover":[190],"limbic":[193],"forebrain":[194],"suppressed":[196],"inflammation,":[198],"abolished":[203],"nor-BNI.":[208],"These":[209],"results":[210],"suggest":[211],"endogenous":[213],"kappa-opioid":[214,228],"systems":[215],"may":[216,230],"be":[217],"activated":[218],"nociception,":[222],"then":[224],"activation":[226],"system":[229],"inhibit":[231],"DA":[232],"release":[233],"nucleus":[235],"accumbens,":[236],"resulting":[237],"morphine.":[249]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2014,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}